GlassScriptPhysician profile
Sidney D Williams
NPI 1770507931
$1,111.69
in general payments reported to CMS, 2019-2025
17 companies · $19.43 in 2025
The $19.43 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $662 · 2020: $104 · 2021: $175 · 2022: $65.70 · 2023: $71.86 · 2024: $13.82 · 2025: $19.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $105.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $238.45 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $147.36 | 2019 | |
| Janssen Pharmaceuticals, INC | $144.17 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $126.47 | 2019-2025 | Belbuca |
| Pacira Therapeutics, INC. | $111.23 | 2019 | |
| Abbvie INC. | $82.26 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $49.69 | 2022-2023 | Austedo, Austedo Xr |
| Novartis Pharmaceuticals Corporation | $31.52 | 2021-2022 | |
| Daiichi Sankyo INC. | $27.50 | 2019 | |
| Pfizer INC. | $27.23 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $26.91 | 2023 | Rexulti |
| Redhill Biopharma INC. | $23.75 | 2021 | |
| Novo Nordisk INC | $18.41 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $17.41 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $13.82 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $13.39 | 2021 | |
| Medtronic USA, INC. | $12.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sidney Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.